Cyberonics (CYBX) - FREE Research Report Wise David S who is SR VP & Chief Admin Officer at Cyberonics sold 2,000 shares at $65.57 on Feb. 5, 2014. Following this transaction, the SR VP & Chief Admin Officer owned 79,055 shares meaning that the stake was reduced by 2.47% with the 2,000-share transaction. The shares most recently traded at $65.58, up $0.01, or 0.02% since the insider transaction. Historical insider transactions for Cyberonics go as follows:
4-Week # shares sold: 4,500
12-Week # shares sold: 37,911
24-Week # shares sold: 66,361
The average volume for Cyberonics has been 254,600 shares per day over the past 30 days. Cyberonics has a market cap of $1.8 billion and is part of the health care sector and health services industry. Shares are up 1.46% year-to-date as of the close of trading on Wednesday. Cyberonics, Inc., together with its subsidiaries, engages in the design, development, marketing, and sale of implantable medical devices to hospitals and ambulatory surgery centers. The company has a P/E ratio of 38.8. Currently there are 7 analysts that rate Cyberonics a buy, no analysts rate it a sell, and 1 rates it a hold. Exclusive Offer: Get the latest Stock Analysis on CYBX - FREETheStreet Quant Ratings rates Cyberonics as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Cyberonics Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.